Table 2.
Roles of m5C enzymes in cancer
Cancer type | Enzyme and relative RNA | Aberrant expression | Target | Effect of targets | Roles in cancer | Refs. |
---|---|---|---|---|---|---|
HCC | NSUN2 | Upregulation | FZR1 mRNA | Enhances stability | Enhances the growth of HCC cells and tumors | [58] |
H19 lncRNA | Enhances stability | Promotes proliferation, migration, invasion, and angiogenesis and inhibits apoptosis | [49] | |||
NOP2 | Upregulation | Unknown | – | Promotes carcinogenesis, cell proliferation, and stem cell-like properties | [125] | |
NSUN4 | Upregulation | Unknown | – | Unknown | [93] | |
Gastric Cancer | NSUN2 | Upregulation | FOXC2 mRNA | Enhances stability | Facilitates proliferation, migration, and invasion | [69] |
p57kip2 mRNA | Represses expression | Promotes the proliferation of GC cells | [39] | |||
GIST | DNMT2 | Upregulation | Unknown | – | Unknown | [142] |
CRC | circNSUN2 | Upregulation | HMGA2 mRNA | Enhances stability | Promotes liver metastasis | [73] |
miR-181a-5p | Repress expression | Enhances ROCK2 expression to promote proliferation and migration and inhibits apoptosis | [46, 70] | |||
NSUN2 | Upregulation | miR-125b | Inhibits processing | Enhances Gab2 expression to promote cell migration | [46] | |
NSUN5 | Upregulation | Unknown | – | Promotes proliferation and maintains cell cycle | [101] | |
Glioma | NSUN5 | Downregulation | 28S rRNA | Deletes m5C3782 | Changes ribosome structure, repressing global protein synthesis | [95] |
Activates stress adaptive translational programs | [95] | |||||
NSUN3, DNMT2 and NOP2 | Upregulation | Unknown | – | Unknown | [22] | |
Breast Cancer | NSUN2, NOP2 | Upregulation | Unknown | – | Promotes proliferation, migration, invasion, and tumorigenicity of cancer cells | [67, 74] |
NSUN6 | Downregulation | MST1 Protein | Inactivation | Activates YAP to promote tumor cell proliferation and bone metastasis | [105] | |
UCB | NSUN2 | Upregulation | HDGF mRNA | Enhances stability | Promotes invasion and metastasis | [10] |
Prostate Cancer | DNMT2 | Upregulation | Unknown | – | Unknown | [148] |
NOP2 | Upregulation | Unknown | – | Promotes metastasis and invasion through the EMT pathway | [18, 19] | |
ccRCC | NSUN6, NSUN5, NSUN2, NOP2 and DNMT2 | Upregulation | Unknown | – | Unknown | [20, 21, 23] |
NSUN3, NSUN4 and NSUN7 | Downregulation | Unknown | – | Unknown | [20, 23] | |
Leukemia | NSUN3, DNMT2 | Undetermined | hnRNPK | Enhances integrity | Involved in forming 5-AZA-sensitive active chromatin structure | [81] |
NOP2 | Undetermined | RNA-pol-II | Unknown | Involved in forming 5-AZA-resistant active chromatin structure | [81] | |
Gallbladder Carcinoma | NSUN2 | Upregulation | Unknown | – | Promotes growth and tumorigenesis | [149] |
LUSC | NSUN3, NSUN4 | Upregulation | Unknown | – | Unknown | [79] |
Lung adenocarcinoma | NOP2 | Upregulation | Unknown | – | Involved in poor differentiation | [26] |
CM | NOP2, NSUN5 | Upregulation | Unknown | – | Unknown | [24] |
NSUN6, NSUN7 | Downregulation | Unknown | – | Unknown | [24] | |
ESCC | NSUN2 | Upregulation | GRB2 mRNA | Enhances stability | Activates PI3K/Akt and ERK/MAPK signaling | [11] |
NMR lncRNA | Unknown | Promotes metastasis and invasion and enhances cisplatin resistance | [50] | |||
HNSCC | NSUN2 | Upregulation | Unknown | – | Unknown | [63, 66] |
HPSCC | NSUN3 | Upregulation | TEAD1 mRNA | Enhances expression | Enhances proliferation and invasion | [71] |
PC | NSUN6 | Downregulation | CDK10 | Enhances expression | Inhibits proliferation | [154] |